Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

340B Orphan Drug Exemption Ruling Opens Up Potential Area For Legislative Compromise

This article was originally published in RPM Report

Executive Summary

On its second try, PhRMA wins the ruling it wanted on exempting products from 340B sales. The commercial impact won’t be huge – but it does give the 340B sector something it needs in a legislative fix.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register